Metallothionein (MT) is a protein that has been widely studiedas a prognostic marker for breast cancer, since it promotes apoptosis, proliferation and differentiation of malignant tumor cells, making them more resistant to treatment8–10. This evidence concerns the gene MCAT and breast cancer.